Business Description
Easywell Biomedicals Inc
NAICS : 339999
SIC : 2834
ISIN : TW0001799005
Description
Easywell Biomedicals Inc is engaged in drug development, manufacturing, and sales of active pharmaceutical ingredients and over-the-counter drug products The company's segment include the Drug development segment and Other segments.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.97 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.62 | |||||
| Debt-to-EBITDA | -15.78 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 7.18 | |||||
| Beneish M-Score | -2.16 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -6.1 | |||||
| 3-Year EBITDA Growth Rate | 6.7 | |||||
| 3-Year EPS without NRI Growth Rate | 11.9 | |||||
| 3-Year FCF Growth Rate | 7.5 | |||||
| 3-Year Book Growth Rate | -9.8 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.86 | |||||
| 9-Day RSI | 35.92 | |||||
| 14-Day RSI | 32.61 | |||||
| 6-1 Month Momentum % | -0.33 | |||||
| 12-1 Month Momentum % | 131.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.91 | |||||
| Quick Ratio | 2.09 | |||||
| Cash Ratio | 1.74 | |||||
| Days Inventory | 178.79 | |||||
| Days Sales Outstanding | 36.07 | |||||
| Days Payable | 42.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.9 | |||||
| Shareholder Yield % | -2.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.69 | |||||
| Operating Margin % | -22.48 | |||||
| Net Margin % | -24.98 | |||||
| FCF Margin % | -34.46 | |||||
| ROE % | -17.37 | |||||
| ROA % | -9.16 | |||||
| ROIC % | -12.62 | |||||
| ROC (Joel Greenblatt) % | -15.82 | |||||
| ROCE % | -9.04 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 15.68 | |||||
| PB Ratio | 10.27 | |||||
| Price-to-Tangible-Book | 13.82 | |||||
| EV-to-EBIT | -77.55 | |||||
| EV-to-EBITDA | -282.76 | |||||
| EV-to-Revenue | 16.8 | |||||
| EV-to-FCF | -49.36 | |||||
| Price-to-Median-PS-Value | 2.73 | |||||
| Price-to-Net-Current-Asset-Value | 195.88 | |||||
| Earnings Yield (Greenblatt) % | -1.28 | |||||
| FCF Yield % | -2.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Easywell Biomedicals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 483.808 | ||
| EPS (TTM) (NT$) | -1.018 | ||
| Beta | 0.73 | ||
| Volatility % | 88.15 | ||
| 14-Day RSI | 32.61 | ||
| 14-Day ATR (NT$) | 5.030835 | ||
| 20-Day SMA (NT$) | 71.11 | ||
| 12-1 Month Momentum % | 131.27 | ||
| 52-Week Range (NT$) | 37.58663 - 233 | ||
| Shares Outstanding (Mil) | 121.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Easywell Biomedicals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Easywell Biomedicals Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Easywell Biomedicals Inc Frequently Asked Questions
What is Easywell Biomedicals Inc(ROCO:1799)'s stock price today?
The current price of ROCO:1799 is NT$66.60. The 52 week high of ROCO:1799 is NT$233.00 and 52 week low is NT$37.59.
When is next earnings date of Easywell Biomedicals Inc(ROCO:1799)?
The next earnings date of Easywell Biomedicals Inc(ROCO:1799) is .
Does Easywell Biomedicals Inc(ROCO:1799) pay dividends? If so, how much?
Easywell Biomedicals Inc(ROCO:1799) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers